Tu et al. examined 404 NSCLC patients and found that radiomics signatures exhibited superior performance (AUC = 0.762 and 0.775 in training and validation cohorts) compared to clinical and morphological features in predicting EGFR mutations (Tu et al., 2019). Here, EGFR is linked to non-small cell lung carcinoma.